Patents by Inventor David Guyer

David Guyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus and methods for sealing a vascular puncture
    Patent number: 12144495
    Abstract: An apparatus for sealing a puncture through a vessel wall including a positioning assembly, a sheath releasably engaged with the positioning assembly, and a support member axially advanceable through the sheath. The positioning assembly includes a positioning element positioned at a distal portion of the positioning assembly and a sealant disposed at a distal portion of the positioning assembly. The sheath guides the sealant and positioning assembly to the puncture in the vessel wall.
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: November 19, 2024
    Assignee: ACCESS CLOSURE, INC.
    Inventors: Ronald R. Hundertmark, Andy H. Uchida, David L. Fiscella, Moshe Zilversmit, Brandon R. Fell, Vincent Ku, Curt Guyer, Richard E. Repp, Mark Sponsel
  • Methods for Treating or Preventing Ophthalmological Conditions
    Publication number: 20150017163
    Abstract: The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
    Type: Application
    Filed: July 11, 2014
    Publication date: January 15, 2015
    Inventors: Samir Patel, Harvey Masonson, David Guyer
  • Methods for treating ocular neovascular diseases
    Publication number: 20070027101
    Abstract: Disclosed herein are methods for treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy.
    Type: Application
    Filed: July 24, 2006
    Publication date: February 1, 2007
    Inventors: David Guyer, Anthony Adamis, Denis O'Shaughnessy
  • Methods and compositions for treating macular degeneration
    Publication number: 20070027102
    Abstract: This invention relates to methods of treating age-related macular degeneration (AMD). In particular, this invention provides methods of treating all forms of wet, age-related macular degeneration. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat wet AMD.
    Type: Application
    Filed: July 24, 2006
    Publication date: February 1, 2007
    Inventors: David Guyer, Anthony Adamis, Denis O'Shaughnessy
  • Methods and compositions for treating ocular disorders
    Publication number: 20060293270
    Abstract: This invention relates to methods of treating ocular disease. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat such disease.
    Type: Application
    Filed: June 22, 2006
    Publication date: December 28, 2006
    Inventors: Anthony Adamis, David Guyer, Marlene Modi
  • Generic packaging tool for packaging application and component therefor to be installed on computing device
    Publication number: 20060031831
    Abstract: To package an application and a component to be available for use in connection with the application into a package, a type of the package and a location where the package is to be stored are received, as is a selection of the component to be packaged with the application. For the selected component, at least one packaging-specific object in such component is referred to to determine information on how to package the component in the package and/or how to install the component on the computing device of the user.
    Type: Application
    Filed: August 4, 2004
    Publication date: February 9, 2006
    Applicant: Microsoft Corporation
    Inventors: David Templin, David Guyer, Michael Wade, Patrick Baker, Sean Draine, Tarik Nesh-Nash
  • Methods and compositions for treating macular degeneration
    Publication number: 20050043220
    Abstract: This invention relates to methods of treating age-related macular degeneration (AMD). In particular, this invention provides methods of treating all forms of wet, age-related macular degeneration. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat wet AMD.
    Type: Application
    Filed: August 27, 2004
    Publication date: February 24, 2005
    Inventors: David Guyer, Denis O'Shaughnessy
  • Plant adenylosuccinate lyase and DNA coding therefor
    Patent number: 5712382
    Abstract: The present invention provides novel plant DNA sequences coding for native adenylosuccinate lyase (ADSL). Methods for using the complete or partial ADSL coding sequence as a probe for diagnostic, mapping and other purposes are taught. Generation of transformed host cells capable of expressing ADSL is also taught. Methods of using the transformed host cells are taught, including methods for recombinant production of ADSL enzymes. A method for using the plant ADSL enzyme to screen for inhibitors of ADSL activity is also provided.
    Type: Grant
    Filed: October 26, 1995
    Date of Patent: January 27, 1998
    Assignee: Novartis Finance Corporation
    Inventors: Charles David Guyer, Eric R. Ward